Home

podmieňovací v prípade sklamať webb jordan 2017 ovarian cancer kanál Armstrong mierny

Cancers | Free Full-Text | Future Screening Prospects for Ovarian Cancer
Cancers | Free Full-Text | Future Screening Prospects for Ovarian Cancer

Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target  Genes in Ovarian Cancer
Cancers | Free Full-Text | An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer

METTL3 promotes the initiation and metastasis of ovarian cancer by  inhibiting CCNG2 expression via promoting the maturation of  pri-microRNA-1246 | Cell Death Discovery
METTL3 promotes the initiation and metastasis of ovarian cancer by inhibiting CCNG2 expression via promoting the maturation of pri-microRNA-1246 | Cell Death Discovery

Epidemiology of Ovarian Cancer (Chapter 1) - Cancer of the Ovary
Epidemiology of Ovarian Cancer (Chapter 1) - Cancer of the Ovary

Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake  and Ovarian Cancer Survival: A Prospective Cohort Study
Frontiers | Pre-diagnosis Cruciferous Vegetables and Isothiocyanates Intake and Ovarian Cancer Survival: A Prospective Cohort Study

Bibliometric analysis of hotspots and frontiers in cancer-related fatigue  among ovarian cancer survivors | PLOS ONE
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE

Bibliometric analysis of hotspots and frontiers in cancer-related fatigue  among ovarian cancer survivors | PLOS ONE
Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors | PLOS ONE

Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal  Trends of Ovarian Cancer: A Global Study
Cancers | Free Full-Text | Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study

IJMS | Free Full-Text | Gene Expression Indicates Altered Immune Modulation  and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to  Topotecan
IJMS | Free Full-Text | Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan

Frontiers | Tumor Microenvironment in Ovarian Cancer: Function and  Therapeutic Strategy
Frontiers | Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy

IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active  Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs
IJMS | Free Full-Text | Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs

Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian  Cancer Carcinogenesis, Progression and Treatment
Pharmaceutics | Free Full-Text | Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment

Statin use and survival among women with ovarian cancer: an Australian  national data-linkage study
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study

Frontiers | Stress Hormones: Emerging Targets in Gynecological Cancers
Frontiers | Stress Hormones: Emerging Targets in Gynecological Cancers

Associate Professor Susan Jordan - School of Public Health - University of  Queensland
Associate Professor Susan Jordan - School of Public Health - University of Queensland

Frontiers | Disease Burden and Attributable Risk Factors of Ovarian Cancer  From 1990 to 2017: Findings From the Global Burden of Disease Study 2017
Frontiers | Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017

Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer  and Upregulates its Expression of Ox40L and 4-1BBL
Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL

CIMB | Free Full-Text | Immunotherapeutic Approaches in Ovarian Cancer
CIMB | Free Full-Text | Immunotherapeutic Approaches in Ovarian Cancer

Medicina | Free Full-Text | Progression Free Survival, Overall Survival,  and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective  Analysis
Medicina | Free Full-Text | Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial- Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis

Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the  Pathogenesis and Progression of Epithelial Ovarian Cancer
Biomedicines | Free Full-Text | The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer

Statin use and survival among women with ovarian cancer: an Australian  national data-linkage study | British Journal of Cancer
Statin use and survival among women with ovarian cancer: an Australian national data-linkage study | British Journal of Cancer

Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer  Screening and Diagnostics: A Comprehensive Review
Cancers | Free Full-Text | Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review

PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in  desensitization to carboplatin in patients with ovarian cancer
PDF) The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer

An epidemiologic risk prediction model for ovarian cancer in Europe: the  EPIC study | British Journal of Cancer
An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study | British Journal of Cancer

Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis  Looking beyond BRCA1 and BRCA2
Cells | Free Full-Text | Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2